期刊
HUMAN VACCINES & IMMUNOTHERAPEUTICS
卷 10, 期 5, 页码 1309-1318出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/hv.28166
关键词
vaccination; oral; antigen delivery vehicles; microparticles; yeast-derived beta-glucan; GALT; Peyer's patches
资金
- Concerted Research Action of the University of Ghent, Ghent, Belgium [BOF10/GOA/21, 01GC2110W]
- Special Research Fund of Ghent University [01D41012]
Oral vaccination is the most challenging vaccination method due to the administration route. However, oral vaccination has socio-economic benefits and provides the possibility of stimulating both humoral and cellular immune responses at systemic and mucosal sites. Despite the advantages of oral vaccination, only a limited number of oral vaccines are currently approved for human use. During the last decade, extensive research regarding antigen-based oral vaccination methods have improved immunogenicity and induced desired immunological outcomes. Nevertheless, several factors such as the harsh gastro-intestinal environment and oral tolerance impede the clinical application of oral delivery systems. To date, human clinical trials investigating the efficacy of these systems are still lacking. This review addresses the rationale and key biological and physicochemical aspects of oral vaccine design and highlights the use of yeast-derived beta-glucan microparticles as an oral vaccine delivery platform.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据